165 related articles for article (PubMed ID: 28931234)
1. The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
de Pokomandy A; Kaufman E; de Castro C; Mayrand MH; Burchell AN; Klein M; Charest L; Auger M; Rodrigues-Coutlée S; Coutlée F;
J Infect Dis; 2017 Aug; 216(4):447-456. PubMed ID: 28931234
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
[TBL] [Abstract][Full Text] [Related]
4. Interest of cytology combined with Xpert
Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.
Kojic EM; Conley L; Bush T; Cu-Uvin S; Unger ER; Henry K; Hammer J; Escota G; Darragh TM; Palefsky JM; Brooks JT; Patel P
J Infect Dis; 2018 Apr; 217(10):1544-1552. PubMed ID: 29452366
[TBL] [Abstract][Full Text] [Related]
7. Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.
Bregar AJ; Cronin B; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M; Robison K
J Low Genit Tract Dis; 2018 Apr; 22(2):115-119. PubMed ID: 29481422
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
Lopez-Cavanillas B; G Benitez C; Serrano M; Sendagorta E; Hernandez A; Bartha JL
J Obstet Gynaecol; 2021 Oct; 41(7):1139-1144. PubMed ID: 33459109
[TBL] [Abstract][Full Text] [Related]
9. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
[TBL] [Abstract][Full Text] [Related]
10. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
[TBL] [Abstract][Full Text] [Related]
13. Anal human papillomavirus DNA in women at a colposcopy clinic.
D'Hauwers KW; Cornelissen T; Depuydt CE; Bogers J; Donders AR; Leuridan E; Van Damme P; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2012 Sep; 164(1):69-73. PubMed ID: 22677508
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
15. High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298.
Cranston RD; Cespedes MS; Paczuski P; Yang M; Coombs RW; Dragavon J; Saah A; Godfrey C; Webster-Cyriaque JY; Chiao EY; Bastow B; Wilkin T;
Sex Transm Dis; 2018 Apr; 45(4):266-271. PubMed ID: 29528986
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus genotypes in anal cytological and histological specimens from HIV-infected men who have sex with men and men who have sex with women.
Darwich L; Videla S; Cañadas MP; Piñol M; García-Cuyàs F; Vela S; Molina-López RA; Coll J; Sirera G; Clotet B;
Dis Colon Rectum; 2013 Sep; 56(9):1043-52. PubMed ID: 23929013
[TBL] [Abstract][Full Text] [Related]
18. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.
Cespedes MS; Kang M; Kojic EM; Umbleja T; Godfrey C; Webster-Cyriaque JY; Masih R; Firnhaber C; Grinsztejn B; Saah A; Cu-Uvin S; Aberg JA
Papillomavirus Res; 2018 Dec; 6():15-21. PubMed ID: 30118852
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India.
Menezes LJ; Poongulali S; Tommasino M; Lin HY; Kumarasamy N; Fisher KJ; Saravanan S; Gheit T; Ezhilarasi C; Jeeva A; Lu B; Giuliano AR
Int J STD AIDS; 2016 Jun; 27(7):543-53. PubMed ID: 26002318
[TBL] [Abstract][Full Text] [Related]
20. Comparison of age-specific patterns of sexual behaviour and anal HPV prevalence in homosexual men with patterns in women.
Poynten IM; Machalek D; Templeton D; Jin F; Hillman R; Zablotzska I; Prestage G; Holt M; Grulich A
Sex Transm Infect; 2016 May; 92(3):228-31. PubMed ID: 26306829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
